In testimony prepared for a Congressional hearing, Mylan CEO Heather Bresch says the company makes about $50 in profit on each EpiPen. Analysts say it's still a hefty margin.
Read more on NPR
Wednesday, 21 September 2016
loobobilly News: Mylan CEO Claims EpiPens Aren't As Profitable As Everyone Thinks
Labels:
Business
,
loobobillyNPR
In testimony prepared for a Congressional hearing, Mylan CEO Heather Bresch says the company makes about $50 in profit on each EpiPen. Analysts say it's still a hefty margin.
Read more on NPR
Do You Like This Article
Get Subscribe to Free Email Updates!!
Popular Posts
-
If you’d like to keep the young ones from seeing inappropriate material in search results, make sure the built-in filter is enabled. If you’...
-
You can put your own computer hardware together from a kit or a collection of parts and you might even be able to run Windows on it. You can...
-
govnanavernisuka : Realness 29TH SEPTEMBER 2016 REBLOGGED FROM GOVNANAVERNISUKA NOTES: 5163 svetlanak...
-
Apple has discussed a partnership with McLaren, the racecar builder, sources say, and is talking with Lit Motors, developer of an electric m...
-
History has witnessed some of the most outstanding achievements by men and women in due course of time. However, the achievement is e...
-
Most web-based email services allow you to download copies of your messages to the computer with a stand-alone mail program. Most web-based ...
-
Quick Facts Everyone knows Narayana Murthy as the one who made Infosys what it is today. More than his management and strategic im...
